Skip to main content
Clinical Trials/ACTRN12607000196448
ACTRN12607000196448
Recruiting
Phase 4

A randomised controlled trial of the effect of high flow verus titrated oxygen therapy on carbon dioxide (CO2) levels in pneumonia

Medical Research Institute of New Zealand0 sites150 target enrollmentApril 5, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pneumonia
Sponsor
Medical Research Institute of New Zealand
Enrollment
150
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 5, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • CoughAt least one systemic feature (sweating, rigors and/or fever \>37\.8 C)Respiratory rate \>18 breaths/min.

Exclusion Criteria

  • Respiratory failure requiring mechanical ventilation; Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)/emphysema; Acute electrocardiogram (ECG) changes suggesting ischaemia; Suspected neutropenic sepsis; Known or suspected chronic hypercapnic respiratory failure as a result of any of the following disorders \- neuromuscular disease, chest wall disease, obesity hypoventilation syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials